Lawrence R. Charnas
Pediatric Neurology | Medical Genetics | Neurology
University Of Minnesota Physicians
516 Delaware Street Se
Minneapolis, MN 55455
516 Delaware Street Se
Minneapolis, MN 55455
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial.
Journal: The Lancet. Infectious diseases
Published: October 28, 2024
Evaluation of Mitochondrial Complex 1 Density with [18F]BCPP-EF in a Murine Model and Individuals with Friedreich Ataxia.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 27, 2024
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: June 07, 2024
Intrathecal Gene Therapy for Giant Axonal Neuropathy.
Journal: The New England journal of medicine
Published: March 20, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
Journal: The American journal of medicine
Published: March 14, 2024
Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
Journal: Scientific reports
Published: March 11, 2022
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
Journal: Journal of neurology
Published: November 23, 2021
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.
Journal: PloS one
Published: November 16, 2021
Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.
Journal: Biomarkers in medicine
Published: September 17, 2021
Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel.
Journal: Open heart
Published: January 20, 2021
Corrigendum to "Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy" [Neuromuscular Disorders, Vol. 30 (6) 2020, 492-502].
Journal: Neuromuscular disorders : NMD
Published: January 16, 2021
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: January 27, 2020
Last Updated: 09/26/2026